DEF 14A

Proxy Statement

Protalix BioTherapeutics, Inc. Filed 2014-10-09 Acc 0001144204-14-060401

Documents 1

DEF 14A Proxy Statement , v390771_def14a.htm

Around this filing

2015-10-01 DEF 14A Proxy Statement
2014-10-09 DEF 14A Proxy Statement
2014-10-06 4 Director disposed of 1,509,948 shares (other)
2013-09-20 DEF 14A Proxy Statement

Link to a passage

External

SEC EDGAR (opens in new tab)